Rezulin (REZ-u-lin, troglitazone), for Type II diabetes

    The FDA is getting close to approving Rezulin (REZ-u-lin, troglitazone), for Type II diabetes.

    It'll be the first drug in a new class of meds for diabetes.

    Troglitazone helps reduce insulin underlying metabolic defect in most patients with Type II diabetes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote